Improving methods to prevent HIV transmission
Statistical Methods for Advancing HIV Prevention
This study is working on better ways to measure how well HIV prevention methods, especially those using medication, are working in real life, so we can help more people stay healthy and reduce the spread of HIV.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fred Hutchinson Cancer Center NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11015850 on NIH RePORTER |
What this research studies
This research focuses on enhancing statistical methods to better measure the effectiveness of HIV prevention strategies, particularly those using antiretroviral therapy. It aims to address the challenges in evaluating real-world impacts of these interventions by developing new trial designs and improving the precision of HIV incidence estimates through innovative statistical approaches. By utilizing HIV recency assays, the study seeks to provide more accurate data on HIV transmission rates, which can inform public health strategies. The ultimate goal is to create more effective and efficient methods for preventing HIV in populations.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at high risk for HIV infection or those involved in HIV prevention efforts.
Not a fit: Patients who are already living with HIV or those who are not at risk for HIV infection may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective HIV prevention strategies, ultimately reducing the incidence of HIV in communities.
How similar studies have performed: Previous research has shown promise in using statistical methods to improve HIV prevention strategies, indicating that this approach has potential for success.
Where this research is happening
Seattle, United States
- Fred Hutchinson Cancer Center — Seattle, United States (Active)
Researchers
- Principal investigator: Gao, Fei — Fred Hutchinson Cancer Center
- Study coordinator: Gao, Fei
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.